Research Analysts Offer Predictions for PG Q2 Earnings

Procter & Gamble Company (The) (NYSE:PG) – Zacks Research decreased their Q2 2026 earnings per share estimates for shares of Procter & Gamble in a research note issued to investors on Friday, November 7th. Zacks Research analyst Team now expects that the company will earn $1.88 per share for the quarter, down from their prior estimate of $1.93. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.91 per share. Zacks Research also issued estimates for Procter & Gamble’s Q4 2026 earnings at $1.55 EPS, FY2026 earnings at $7.00 EPS, Q2 2027 earnings at $2.00 EPS, Q4 2027 earnings at $1.65 EPS, FY2027 earnings at $7.41 EPS, Q1 2028 earnings at $2.22 EPS and FY2028 earnings at $7.88 EPS.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. The business had revenue of $22.39 billion during the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The business’s revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS.

Several other equities analysts also recently issued reports on PG. BNP Paribas reaffirmed an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Barclays decreased their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. BNP Paribas Exane decreased their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Finally, UBS Group dropped their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Twelve investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $171.53.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $146.90 on Monday. The stock has a market capitalization of $343.28 billion, a P/E ratio of 21.45, a P/E/G ratio of 3.87 and a beta of 0.36. The company’s fifty day moving average price is $152.93 and its 200 day moving average price is $157.02. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. Procter & Gamble has a 1 year low of $144.46 and a 1 year high of $180.43.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a $1.0568 dividend. The ex-dividend date is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio is 61.61%.

Insider Activity

In other Procter & Gamble news, CEO Jon R. Moeller sold 40,119 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the transaction, the chief executive officer owned 319,375 shares of the company’s stock, valued at approximately $50,228,106.25. The trade was a 11.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the sale, the insider owned 182,422 shares of the company’s stock, valued at approximately $28,689,507.94. The trade was a 5.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 150,488 shares of company stock valued at $23,529,718 in the last 90 days. 0.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Procter & Gamble

Institutional investors and hedge funds have recently bought and sold shares of the company. Nova Wealth Management Inc. purchased a new position in Procter & Gamble in the first quarter worth approximately $26,000. Halbert Hargrove Global Advisors LLC acquired a new position in shares of Procter & Gamble in the 3rd quarter valued at $25,000. Signature Resources Capital Management LLC grew its holdings in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after purchasing an additional 72 shares during the period. Quarry LP acquired a new stake in shares of Procter & Gamble during the 1st quarter worth about $33,000. Finally, Corundum Trust Company INC purchased a new stake in Procter & Gamble in the 3rd quarter valued at about $32,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.